TAS-102 Clinical Trials

3 actively recruiting trials across 2 locations

▼ -1 trial since May 2026

Also known as: LONSURF, Lonsurf, tipiracil, trifluoridine and tipiracil, trifluridine

Pipeline

Phase 1: 2Phase 2: 1

Top Sponsors

University of California, Irvine1
Taiho Pharmaceutical Co., Ltd.1
M.D. Anderson Cancer Center1

Indications

Colorectal Cancer3
Cancer3
Alveolar Soft Part Sarcoma1
Advanced or Metastatic Solid Tumor1
Colon Adenocarcinoma1

Other1 trial

AB122 Platform Study

Phase 1

Orange, California1 trial

Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas

Chao Family Comprehensive Cancer Center, University of California, Irvine

Phase 1

Houston, Texas1 trial

TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

MD Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.